| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.231 | 14.240 | 14.372 | 12.683 | 7.990 | 12.966 | 4.236 | 14.609 | 6.688 | 15.445 |
| Total Income - EUR | 25.249 | 14.283 | 14.373 | 12.683 | 7.990 | 12.966 | 4.236 | 14.609 | 6.688 | 15.445 |
| Total Expenses - EUR | 23.111 | 14.909 | 16.032 | 13.311 | 7.145 | 11.066 | 4.031 | 13.047 | 5.538 | 13.126 |
| Gross Profit/Loss - EUR | 2.139 | -626 | -1.658 | -628 | 845 | 1.900 | 205 | 1.562 | 1.150 | 2.319 |
| Net Profit/Loss - EUR | 1.381 | -1.054 | -2.089 | -1.008 | 605 | 1.511 | 78 | 1.123 | 966 | 1.948 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Prodimpexal Com S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.939 | 5.148 | 2.880 | 2.367 | 1.604 | 2.114 | 1.554 | 2.010 | 1.443 | 2.897 |
| Inventories | 2.827 | 2.744 | 2.350 | 1.752 | 1.543 | 1.514 | 1.481 | 1.238 | 1.234 | 1.207 |
| Receivables | 236 | 32 | 194 | 47 | 0 | 226 | 0 | 564 | 11 | 626 |
| Cash | 1.875 | 2.372 | 335 | 569 | 60 | 374 | 73 | 208 | 197 | 1.064 |
| Shareholders Funds | -4.935 | -5.939 | -7.927 | -8.790 | -8.015 | -6.352 | -6.133 | -5.028 | -4.047 | -2.077 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.906 | 11.135 | 10.860 | 11.205 | 9.619 | 8.465 | 7.687 | 7.038 | 5.490 | 4.974 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Prodimpexal Com S.r.l.